Cargando…
Statin adherence is lower in primary than secondary prevention: A national follow-up study of new users
BACKGROUND: Maintaining adherence to statins reduces the risk of an initial cardiovascular disease (CVD) event in high-risk individuals (primary prevention) and additional CVD events following the first event (secondary prevention). The effectiveness of statin therapy is limited by the level of adhe...
Autores principales: | Sigglekow, Finn, Horsburgh, Simon, Parkin, Lianne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7676659/ https://www.ncbi.nlm.nih.gov/pubmed/33211724 http://dx.doi.org/10.1371/journal.pone.0242424 |
Ejemplares similares
-
Treatment pathways in people with type 2 diabetes mellitus: a nationwide cohort study of new users of metformin monotherapy in New Zealand
por: Guo, Joyce, et al.
Publicado: (2021) -
Adherence to Statins in Primary Prevention: Yearly Adherence Changes and Outcomes
por: Slejko, Julia F., et al.
Publicado: (2014) -
Cholesterol lowering for secondary prevention: What statin dose should we use?
por: Josan, Kiranbir, et al.
Publicado: (2007) -
Statins and the Brain: More than Lipid Lowering Agents?
por: Fracassi, Anna, et al.
Publicado: (2019) -
Patterns of prescription medicine dispensing before and during pregnancy in New Zealand, 2005–2015
por: Donald, Sarah, et al.
Publicado: (2020)